Bank of New York Mellon
TBIO

Bank of New York Mellon’s Telesis Bio, Inc. Common Stock TBIO Stock Holding History

Bank of New York Mellon’s Portfolio TBIO Stock Details TBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-962
Closed -$93K – 4722
2022
Q1 		$93K Buy
962
+37
+4% +$5.61K ﹤0.01% 4419
2021
Q4 		$180K Buy
925
+139
+18% +$21.6K ﹤0.01% 4311
2021
Q3 		$157K Buy
+786
New +$199K ﹤0.01% 4254

Other funds holding TBIO

NV
Northpond Ventures Bethesda, Maryland $43.7M AUM 27.27% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
PCM
Penn Capital Management Philadelphia, Pennsylvania $1.58B AUM 81.2% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PM
Penbrook Management New York $157M AUM 46.57% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bank of New York Mellon's TBIO Position: Q2 2022 in Review

Bank of New York Mellon sold out of Telesis Bio, Inc. Common Stock (TBIO) in Q2 2022, closing a stake of 962 shares — an estimated $93K sold.

Bank of New York Mellon first reported a position in TBIO in Q3 2021 and held it in 3 quarters. The position peaked at $180K in Q4 2021. 37 funds tracked by Wall St. Rank hold TBIO as of Q2 2022.

  • Bank of New York Mellon reported no remaining Telesis Bio, Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
  • Bank of New York Mellon sold 962 Telesis Bio, Inc. Common Stock shares in Q2 2022, an estimated $93K.
  • Bank of New York Mellon first reported a position in Telesis Bio, Inc. Common Stock in Q3 2021 and held it in 3 quarters.
  • Bank of New York Mellon's Telesis Bio, Inc. Common Stock position peaked at $180K in Q4 2021.
  • 37 funds tracked by Wall St. Rank held Telesis Bio, Inc. Common Stock as of Q2 2022.

Based on Bank of New York Mellon's 13F filing for Q2 2022, filed 15 Aug 2022.